Macrolides have diverse biological activities and an ability to modulate inflammation and
immunity in eukaryotes without affecting homeostatic immunity. These properties have led to …

Background Macrolides have long been recognised to exert immunomodulary and anti-
inflammatory actions. They are able to suppress the “cytokine storm” of inflammation and to …

Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplantation
(HCT) is associated with high mortality. We hypothesized that inhaled fluticasone …

The full British Thoracic Society (BTS) guideline for the use of long-term macrolides in adults
with respiratory disease is published in Thorax. The following is a summary of the …

Tens of thousands of patients undergo hematopoietic stem cell transplantation (HSCT)
annually, 15 to 40% of whom are admitted to the intensive care unit. Pulmonary …

Chronic graft-versus-host disease (cGvHD) is a common complication after allogeneic
haematopoietic stem cell transplantation, characterised by a broad disease spectrum that …

This consensus statement established under the auspices of the German working group on
BM and blood stem cell transplantation (DAG-KBT), the German Society of Hematology and …

Azithromycin has a well-characterized bacteriostatic activity. However, it also has a robust
immunomodulatory effect that has proven beneficial in a variety of chronic illnesses. This …

In past years, a diagnosis of bronchiolitis obliterans syndrome (BOS) after allogeneic
hematopoietic cell transplant (HCT) conferred nearly universal mortality secondary to lack of …

With improvements in supportive care, both long-term survival following allogeneic
hematopoietic stem cell transplantations (HSCTs) and the indications for this procedure …